๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan

โœ Scribed by Motohiro NOZAWA; Yosuke ICHIMIYA; Eiko NOZAWA; Yushi UTUMI; Hideki SUGIYAMA; Norio MURAYAMA; Eizo ISEKI; Heii ARAI

Book ID
109059069
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
73 KB
Volume
9
Category
Article
ISSN
1346-3500

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Preliminary communication: Urodynamic as
Preliminary communication: Urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease
โœ Ryuji Sakakibara; Tomoyuki Uchiyama; Mitsuharu Yoshiyama; Tomoyuki Yamanishi; Ta ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB

## Abstract ## Background and Aims Donepezil hydrochloride, a central cholinergic drug, is widely used for improving cognitive decline in Alzheimer's disease (AD). We investigated whether donepezil might affect the lower urinary tract (LUT) function in AD. ## Methods Alzheimer's Disease Assessme

Potential treatment effects of donepezil
Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey
โœ Kenneth Rockwood; Sandra E. Black; Alain Robillard; Isabelle Lussier ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

## Abstract ## Objectives Clinical trials of the cholinesterase inhibitor donepezil have used standard psychometric tools to evaluate treatment efficacy. These trials, however, appear not to capture clinically demonstrable, but otherwise unmeasured, beneficial treatment effects. We sought to ident